Danaher Corporation (N:DHR)

Business Focus: Advanced Medical Equipment & Technology

Jul 23, 2020 08:00 am ET
Beckman Coulter's Automated Blood Banking Analyzer Receives 510(k) FDA Clearance
BREA, Calif., July 23, 2020 /PRNewswire/ -- Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have completed FDA approval. Designed for use in blood donor and plasma centers, as well as large reference laboratories, the PK7400 Automated Microplate System offers the industry's highest throughput for a single analyzer in its class and is now available in countries across Europe, Canada and the United States....
Jul 23, 2020 06:00 am ET
Danaher Reports Second Quarter 2020 Results
WASHINGTON, July 23, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended July 3, 2020.  All results in this release reflect only continuing operations unless otherwise noted....
Jul 21, 2020 04:52 pm ET
Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year
BREA, Calif., July 21, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientists' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000 Total Laboratory Automation System, as well as the Reviewer's Choice Award for Clinical Customer Service of the Year. The awards were presented by SelectScience® at the SelectScience Virtual Clinical Chemistry Summit, held July 20-22, 2020....
Jul 17, 2020 09:15 am ET
Beckman Coulter Receives Nine IMV ServiceTrak™ Clinical Laboratory Awards
BREA, Calif., July 17, 2020 /PRNewswire/ -- Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories. The company's Immunoassay, Integrated Systems and Urinalysis instruments received IMV ServiceTrak's "Best System Performance" top honors; its Chemistry, Immunoassay, Integrated Systems, AST/ID (Microbiology), and Urinalysis systems were awarded "Best Service"; and the company's Urinalysis system received the "Best Customer Satisfaction Award."...
Jul 16, 2020 07:00 am ET
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
Xpert® MTB/XDR cartridge enables expanded drug-resistance profiling in less than 90 minutes Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), the test could help fill a critical gap that is currently jeopardizing global TB targets GENEVA and SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which enables expanded drug-resistance tuberculosis (TB) profiling in less tha...
Jul 16, 2020 07:00 am ET
New Rapid Molecular Test For Tuberculosis Can Simultaneously Detect Resistance To First- And Second-Line Drugs
Xpert® MTB/XDR cartridge enables expanded drug-resistance profiling in less than 90 minutes Used to empower clinicians to quickly prescribe treatment regimens for multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), the test could help fill a critical gap that is currently jeopardizing global TB targets GENEVA and SUNNYVALE, Calif., July 16, 2020 /CNW/ -- The Foundation for Innovative New Diagnostics (FIND) and Cepheid, Inc, announced today the launch of the new Xpert® MTB/XDR* test, which enables expanded drug-resistance tuberculosis (TB) profiling in less than 90 mi...
Jul 13, 2020 04:15 pm ET
Danaher Schedules Second Quarter 2020 Earnings Conference Call
WASHINGTON, July 13, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Jul 09, 2020 11:00 am ET
Fully Integrated SCIEX OS Software Launches at Virtual Product Experience
SCIEX, a global leader in life science analytical technologies, introduces the fully integrated SCIEX OS Software, the core engine running SCIEX innovations. Today, SCIEX OS Software becomes available on the Echo® MS System and the SCIEX Triple Quad™ 7500 LC-MS/MS System – QTRAP® Ready.
Jun 29, 2020 08:00 am ET
Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization
BREA, Calif., June 29, 2020 /PRNewswire/ -- Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and has begun distribution of the new antibody test globally to countries that accept the FDA EUA and CE Mark. The company is able to deliver more than 30 million tests a month. ...
Jun 09, 2020 07:00 am ET
Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV
SUNNYVALE, Calif., June 9, 2020 /PRNewswire/ -- Cepheid today announced the development of a next-generation test to assist global efforts in the fight against the spread of COVID-19 during the upcoming respiratory virus season. The Xpert® Xpress SARS-CoV-2/Flu/RSV four-in-one test is expected to deliver qualitative detection of SARS-CoV-2, Flu A, Flu B and RSV from a single patient sample. The test is designed for use on any of Cepheid's more than 25,000 GeneXpert® Systems placed worldwide, with results expected in as little as 35 minutes....
May 28, 2020 12:06 pm ET
FDA Lists Beckman Coulter Life Sciences RNA Extraction Kit For Use In EUA-Authorized COVID-19 Test
INDIANAPOLIS, May 28, 2020 /PRNewswire/ -- Beckman Coulter Life Sciences today announced RNAdvance Viral XP has been added to the list of acceptable extraction methods for use in the Centers for Disease Control's EUA-authorized COVID-19 test referenced in the FDA's FAQ on testing for SARS-CoV-2. Laboratories are now permitted to independently validate RNAdvance Viral XP for use....
May 18, 2020 11:49 am ET
Beckman Coulter launches DxH 690T mid-volume hematology analyzer, featuring the Early Sepsis Indicator in U.S. market
BREA, Calif., May 18, 2020 /PRNewswire/ -- Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T delivers all of the benefits of the company's flagship DxH 900 large-volume hematology analyzer in a table-top configuration....
May 12, 2020 04:10 pm ET
Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering
WASHINGTON, May 12, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,717,500 shares of 5.00% Series B Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the "offerings"). These offerings were made by means of separate prospectus supplements and were not contingent on each other. The shares of Series B Mandatory Convertible Preferred Stock sold include 167,500 shares issued pursuant to the exercise in f...
May 08, 2020 01:15 am ET
Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering
WASHINGTON, May 8, 2020 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 9,509,203 shares of common stock at a price to the public of $163.00 per share and 1,550,000 shares of 5.00% Series B Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The underwriters have separate 30-day options to purchase up to an additional 1,426,379 shares of common stock, and up to an additional 167,500 shares of mandatory convertible preferred stock.  The offerings are scheduled to be completed ...
May 07, 2020 08:40 am ET
Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock
WASHINGTON, May 7, 2020 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.25 billion of shares of common stock and $1.25 billion of shares of Series B Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings). Danaher expects to grant the underwriters separate 30-day options to purchase up to an additional $187.5 million of shares of common stock, and up to an additional $187.5 million of shares of mandatory convertible preferred stock....
May 06, 2020 04:10 pm ET
Danaher Corporation Announces CEO Transition
WASHINGTON, May 6, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive Officer and as a member of the Company's Board of Directors, upon Mr. Joyce's retirement from these positions on September 1, 2020. Mr. Joyce will continue as a senior advisor at Danaher through February 28, 2021. ...
May 06, 2020 04:10 pm ET
Danaher Reports First Quarter 2020 Results
WASHINGTON, May 6, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended April 3, 2020.  All results in this release reflect only continuing operations unless otherwise noted....
May 05, 2020 04:10 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, May 5, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.18 per share of its common stock, payable on July 31, 2020 to holders of record on June 26, 2020. In addition, Danaher announced today that its Board of Directors has approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on July 15, 2020 to holders of record on June 30, 2020. ...
Apr 30, 2020 09:00 am ET
Danaher Completes Sale Of Certain Businesses To Sartorius AG To Satisfy Regulatory Requirement For Cytiva Acquisition
WASHINGTON, April 30, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today it completed the sale of its label-free biomolecular characterization, chromatography hardware and resins, microcarriers and particle validation standards, single use tangential flow filtration systems, and stainless steel hollow fiber tangential flow filtration systems businesses to Sartorius AG for approximately $825 million. The combined revenue of the businesses, which were part of Danaher's Life Sciences segment, was approximately $170 million in 2019....
Apr 24, 2020 09:31 am ET
Thinking about trading options or stock in Comcast, CVS Health, Danaher Corp, Edwards Lifesciences, or NVIDIA?
NEW YORK, April 24, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CMCSA, CVS, DHR, EW, and NVDA....
Apr 17, 2020 06:45 am ET
Danaher Corporation Changes Its Annual Shareholders Meeting To A Virtual Format
WASHINGTON, April 17, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced today that, due to the public health impact of COVID-19, the Company will hold its 2020 Annual Meeting of Shareholders in a virtual meeting format only, via audio webcast.  The date and time of the meeting and the proposals to be presented to shareholders at the meeting are unchanged.  The meeting webcast will be held on Tuesday, May 5, 2020 at 3:00 p.m. Eastern Time....
Apr 13, 2020 06:45 am ET
Danaher Provides Update On First Quarter 2020 Financial Performance And Schedules First Quarter Earnings Conference Call
WASHINGTON, April 13, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced today that for the quarter ended April 3, 2020 it expects revenue growth of approximately 3.0% and non-GAAP core revenue growth of approximately 4.5%....
Apr 03, 2020 04:45 pm ET
Danaher Prices Reopening Of Euro-Denominated Senior Notes
WASHINGTON, April 3, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced a reopening of:...
Mar 31, 2020 06:00 pm ET
Danaher Completes Acquisition Of The Biopharma Business Of General Electric Life Sciences; Business Will Be Called Cytiva
WASHINGTON, March 31, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today the completion of its acquisition of the Biopharma business from General Electric Company's (NYSE: GE) Life Sciences division. As part of Danaher, the business will be called Cytiva and will be a standalone operating company within Danaher's Life Sciences segment....
Mar 25, 2020 09:15 pm ET
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering
WASHINGTON, March 25, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of:...
Mar 21, 2020 09:00 am ET
Cepheid Receives Emergency Use Authorization from FDA for Rapid SARS-CoV-2 Test
SUNNYVALE, Calif., March 21, 2020 /PRNewswire/ -- Cepheid today announced it has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA) for Xpert® Xpress SARS-CoV-2, a rapid molecular diagnostic test for qualitative detection of SARS-CoV-2, the virus causing COVID-19. The test has been designed to operate on any of Cepheid's more than 23,000 automated GeneXpert® Systems worldwide, with a detection time of approximately 45 minutes. ...
Mar 19, 2020 06:50 pm ET
Danaher Receives Clearance From U.S. Federal Trade Commission For The Acquisition Of The Biopharma Business Of General Electric Life Sciences
WASHINGTON, March 19, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that the U.S. Federal Trade Commission (the "FTC") has accepted the proposed consent order in connection with Danaher's definitive agreement with General Electric Company ("GE") (NYSE: GE) to acquire the Biopharma business of GE Life Sciences ("GE Biopharma"). ...
Nov 15, 2019 05:30 am ET
Danaher Will Commence Exchange Offer Related To Divestiture Of Its Remaining Interest In Envista Through A Split-Off
WASHINGTON, Nov. 15, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will commence an exchange offer related to the split-off of its remaining interest in Envista Holdings Corporation (NYSE: NVST). Envista completed its initial public offering (IPO) in September 2019, with Danaher retaining an 80.6 percent ownership interest in Envista. In the exchange offer, Danaher stockholders have the option to exchange all, some or none of their shares of Danaher common stock for shares of Envista common stock owned by Danaher, subject to the terms of the offer. The exchange...
Nov 15, 2019 05:30 am ET
Envista To File Registration Statement In Connection With Danaher Exchange Offer Announcement
BREA, Calif., Nov. 15, 2019 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced it intends to file a Form S-4/S-1 Registration Statement today with the Securities and Exchange Commission (SEC) in connection with Danaher's (NYSE: DHR) proposed offer to exchange shares of Envista common stock it owns for shares of Danaher common stock. In the offer, Danaher shareholders will have the opportunity to exchange some or all their shares of Danaher common stock for shares of Envista common stock. The exchange offer is anticipated to be tax-free for participating Danaher shareholders ...
Nov 13, 2019 03:15 pm ET
Danaher Announces Appointment of Jessica L. Mega, MD, MPH and Pardis C. Sabeti MD, D.Phil to Danaher Board
WASHINGTON, Nov. 13, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Jessica L. Mega, MD, MPH and Pardis C. Sabeti, MD, D.Phil to its Board of Directors....
Oct 29, 2019 11:01 pm ET
Danaher Announces Pricing Of Senior Notes Offering
WASHINGTON, Oct. 29, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of:...
Oct 28, 2019 04:15 pm ET
Danaher To Present At Baird Global Industrial Conference
WASHINGTON, Oct. 28, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday, November 5, 2019 at 10:30 a.m. CT. The audio will be simultaneously webcast on and the presentation will be archived on  www.danaher.com.  ...
Oct 24, 2019 06:00 am ET
Danaher Reports Third Quarter 2019 Results
WASHINGTON, Oct. 24, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2019. For the quarter ended September 27, 2019, net earnings attributable to Danaher common stockholders were $648.4 million, or $0.89 per diluted share which represents a 4.5% year-over-year decrease from the comparable 2018 period....
Oct 21, 2019 01:00 am ET
Danaher Reaches Agreement To Sell Certain Businesses To Sartorius AG As Part Of The GE Biopharma Acquisition Regulatory Process
WASHINGTON, Oct. 21, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that it has signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius AG for approximately $750 million. The combined revenue of the businesses, which are part of Danaher's Life Sciences segment, was approximately $140 million in 2018....
Oct 09, 2019 04:15 pm ET
Danaher Schedules Third Quarter 2019 Earnings Conference Call
WASHINGTON, Oct. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2019 on Thursday, October 24, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Sep 23, 2019 04:27 pm ET
Danaher Announces Redemption Of Senior Notes
WASHINGTON, Sept. 23, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it will redeem all of its $500,000,000 aggregate principal amount of 2.400% Senior Notes due 2020 (the "Danaher 2020 Notes") and all of the $375,000,000 aggregate principal amount of 5.00% Senior Notes due 2020 originally issued by Pall Corporation and subsequently guaranteed by Danaher (the "Pall 2020 Notes" and together with the Danaher 2020 Notes, the "Notes"), in each case at a redemption price equal to the outstanding principal amount and a make-whole premium as specified in the a...
Sep 20, 2019 04:15 pm ET
Envista Announces IPO Closing
BREA, Calif., Sept. 20, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. In connection with the IPO, the underwriters exercised in full their option to purchase an additional 4,015,200 shares of common stock at the price to the public less underwriting discounts, bringing the total IPO size to 30,783,200 shares. The shares began trading on the New York Stock Exchange on S...
Sep 17, 2019 07:51 pm ET
Envista Announces Pricing of Initial Public Offering
BREA, Calif., Sept. 17, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), announced today the pricing of its initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share. The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "NVST." The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $588,896,000, excluding any exercise of the underwriters' option to purchase a...
Sep 10, 2019 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 10, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on October 25, 2019 to holders of record on September 27, 2019. In addition, Danaher announced today that its Board of Directors has approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on October 15, 2019 to holders of record on September 30, 2019. ...
Sep 09, 2019 04:35 pm ET
Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach
WASHINGTON, Sept. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Water Quality Platform Investor and Analyst Meeting at Hach on September 17, 2019 beginning at 8:00 a.m. MT. The event will be held at Danaher's Hach facility in Loveland, Colorado and hosted by Joakim Weidemanis, Executive Vice President of the Water Quality and Product Identification platforms, and Matt McGrew, Executive Vice President and Chief Financial Officer. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's w...
Sep 04, 2019 07:14 am ET
Envista Announces Launch of IPO Roadshow
BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock....
Sep 03, 2019 09:10 pm ET
Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering
WASHINGTON, Sept. 3, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International II"), has priced an offering of:...
Jul 18, 2019 06:00 am ET
Danaher Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / July 18, 2019 / Danaher Corp. (NYSE: DHR) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 18, 2019 at 8:00 AM Eastern Time.
Jul 18, 2019 06:00 am ET
Danaher Reports Second Quarter 2019 Results
WASHINGTON, July 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019, net earnings were $731.3 million, or $0.97 per diluted share which represents a 2.0% year-over-year increase from the comparable 2018 period....
May 23, 2019 04:15 pm ET
Danaher To Present At Bernstein Strategic Decisions Conference
WASHINGTON, May 23, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, May 30, 2019 at 8:00 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ...
May 08, 2019 04:15 pm ET
Danaher to Present at Bank of America Merrill Lynch Health Care Conference
WASHINGTON, May 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Rainer Blair, will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 15, 2019 at 8:00 a.m. PT. The audio will be simultaneously webcast on www.danaher.com.  ...
May 07, 2019 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, May 7, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, payable on July 26, 2019 to holders of record on June 28, 2019. In addition, Danaher announced today that its Board of Directors has approved a quarterly cash dividend of $17.681 per share of its 4.75% Series A Mandatory Convertible Preferred Stock, payable on July 15, 2019 to holders of record on June 30, 2019. ...
Apr 18, 2019 06:00 am ET
Danaher Reports First Quarter 2019 Results
WASHINGTON, April 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019. For the quarter ended March 29, 2019, net earnings were $333.8 million, or $0.46 per diluted share which represents a 41.0% year-over-year decrease from the comparable 2018 period....
Mar 19, 2019 04:15 pm ET
Danaher Schedules First Quarter 2019 Earnings Conference Call
WASHINGTON, March 19, 2019 /PRNewswire/ --Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Mar 08, 2019 03:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, March 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share payable on April 26, 2019 to holders of record on March 29, 2019. ...
Mar 06, 2019 08:20 am ET
Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Sally Beauty Holdings, Inc....
Mar 01, 2019 04:00 pm ET
Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering
WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). These offerings were made by means of separate prospectus supplements and were not contingent on each other. The amounts sold include 1,100,000 shares of common stock and 150,000 shares of Mandatory Convertible Preferred Stock issued ...
Feb 26, 2019 10:15 pm ET
Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering
WASHINGTON, Feb. 26, 2019 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.00 per share and 1,500,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The underwriters have separate 30-day options to purchase up to an additional 1,100,000 shares of common stock, and up to an additional 150,000 shares of mandatory convertible preferred stock.  The offerings are scheduled to be c...
Feb 25, 2019 04:12 pm ET
Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock
WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.35 billion of shares of common stock and $1.35 billion of shares of Series A Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings). Danaher expects to grant the underwriters separate 30-day options to purchase up to an additional $135 million of shares of common stock, and up to an additional $135 million of shares of mandatory convertible preferred stock....
Feb 25, 2019 06:00 am ET
Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion
WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive agreement with General Electric Company ("GE") (NYSE: GE) to acquire the Biopharma business of GE Life Sciences ("GE Biopharma") for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net purchase price is approximately $20 billion. This represents a multiple of approximately 17 times expected 2019 EBITDA for GE Biopharma....
Feb 13, 2019 03:15 pm ET
Danaher To Present At Barclays Industrial Select Conference
WASHINGTON, Feb. 13, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, and Executive Vice President, Joakim Weidemanis, will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Wednesday, February 20, 2019 at 9:45 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ...
Jan 31, 2019 07:30 am ET
Investor Expectations to Drive Momentum within E*TRADE Financial, Alliant Energy, DENTSPLY SIRONA, Danaher, Aspen Technology, and Marin Software — Discovering Underlying Factors of Influence
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of E*TRADE Financial Corporation (NASDAQ:ETFC), Alliant Energy Corporation...
Jan 29, 2019 05:00 am ET
Danaher Reports Fourth Quarter And Full Year 2018 Results
WASHINGTON, Jan. 29, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2018. For the quarter ended December 31, 2018, net earnings were $746.8 million, or $1.05 per diluted share, representing a 13.0% year-over-year decrease....
Jan 07, 2019 07:15 pm ET
Danaher CEO To Comment On Financial Performance
WASHINGTON, Jan. 7, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2018 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate that fourth quarter 2018 core revenue growth is expected to be above the Company's previously announced guidance and adjusted diluted net earnings per share is expected to be at or near the high-end of the Company's previously...
Jan 02, 2019 03:15 pm ET
Danaher To Present At J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 2, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 8, 2019 at 8:00 a.m. PT. The audio will be simultaneously webcast on and the presentation will be archived on  www.danaher.com.  ...
Dec 27, 2018 03:15 pm ET
Danaher Schedules Fourth Quarter 2018 Earnings Conference Call
WASHINGTON, Dec. 27, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2018 on Tuesday, January 29, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Dec 13, 2018 05:00 am ET
Danaher Initiates 2019 Outlook
WASHINGTON, Dec. 13, 2018 /PRNewswire/ -- Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (NYSE: DHR) (the "Company") initiated its 2019 outlook. The Company anticipates that 2019 diluted net earnings per share will be in the range of $4.02 to $4.12....
Dec 06, 2018 08:20 am ET
Recent Analysis Shows American Express, Ryanair, Chubb, CNA Financial, Danaher, and Randgold Resources Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of American Express Company (NYSE:AXP), Ryanair Holdings PLC...
Dec 03, 2018 03:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Dec. 3, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on January 25, 2019 to holders of record on December 28, 2018. ...
Nov 13, 2018 05:00 pm ET
Danaher To Webcast Investor And Analyst Meeting
WASHINGTON, Nov. 13, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting in New York City on December 13, 2018 beginning at 9:30 a.m. ET. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the video webcast will be available following the presentation.  ...
Oct 30, 2018 04:15 pm ET
Danaher to Present at Baird Global Industrial Conference
WASHINGTON, Oct. 30, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird Global Industrial Conference in Chicago on Tuesday, November 6, 2018 at 9:30 a.m. CT. The audio will be simultaneously webcast on and the presentation will be archived on www.danaher.com.  ...
Oct 29, 2018 08:40 am ET
Report: Developing Opportunities within Danaher, Steel Dynamics, Kansas City Southern, Cinemark, Scotts Miracle-Gro, and Nucor — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Danaher Corporation (NYSE:DHR), Steel Dynamics, Inc. (NASDAQ:STLD),...
Oct 18, 2018 06:00 am ET
Danaher Reports Third Quarter 2018 Results
WASHINGTON, Oct. 18, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2018. For the quarter ended September 28, 2018, net earnings were $663.7 million, or $0.93 per diluted share which represents a 15.0% year-over-year increase....
Oct 01, 2018 04:15 pm ET
Danaher Schedules Third Quarter 2018 Earnings Conference Call
WASHINGTON, Oct. 1, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2018 on Thursday, October 18, 2018 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Sep 17, 2018 04:15 pm ET
Danaher To Webcast Mid-Year Investor And Analyst Meeting At Pall
WASHINGTON, Sept. 17, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Mid-Year Investor and Analyst Meeting at Pall on September 18, 2018 beginning at 12:00 p.m. ET. The event will be held at Danaher's Pall facility in Westborough, Massachusetts and hosted by Rainer Blair, Executive Vice President of the Life Sciences platform, and Daniel L. Comas, Executive Vice President and Chief Financial Officer. A link to the webcast and accompanying slide presentation will be available on the "Investors" section of Danaher's website, www.danaher.com, under th...
Sep 11, 2018 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 11, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on October 26, 2018 to holders of record on September 28, 2018. ...
Sep 10, 2018 04:15 pm ET
Danaher To Present At Morgan Stanley Global Healthcare Conference
WASHINGTON, Sept. 10, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Morgan Stanley Global Healthcare Conference in New York City on Friday, September 14, 2018 at 8:45 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ...
Aug 09, 2018 08:30 am ET
Report: Developing Opportunities within New Residential Investment, Danaher, American Electric Power, Energen, W&T Offshore, and Diamond Offshore Drilling — Future Expectations, Projections Moving int
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of New Residential Investment Corp. (NYSE:NRZ), Danaher Corporation...
Jul 19, 2018 06:00 am ET
Danaher Announces Plan To Spin Off Dental Business Into An Independent, Publicly Traded Company
WASHINGTON, July 19, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced its intention to spin off its Dental segment into an independent, publicly-traded company ("DentalCo"). The transaction is intended to be tax-free to Danaher shareholders and expected to be completed in the second half of 2019....
Jul 19, 2018 06:00 am ET
Danaher Reports Second Quarter 2018 Results
WASHINGTON, July 19, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2018. For the quarter ended June 29, 2018, net earnings were $673.8 million, or $0.95 per diluted share which represents a 20.0% year-over-year increase....
Jun 20, 2018 04:15 pm ET
Danaher Schedules Second Quarter 2018 Earnings Conference Call
WASHINGTON, June 20, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2018 on Thursday, July 19, 2018 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
May 24, 2018 04:15 pm ET
Danaher To Present At Bernstein Strategic Decisions Conference
WASHINGTON, May 24, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, May 31, 2018 at 11:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 08, 2018 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, May 8, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on July 27, 2018 to holders of record on June 29, 2018. ...
May 08, 2018 07:40 am ET
Report: Developing Opportunities within Cboe Global Markets, Colgate-Palmolive, Conduent, Danaher, Jacobs Engineering Group, and Interactive Brokers Group — Future Expectations, Projections Moving int
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cboe Global Markets, Inc. (NASDAQ:CBOE), Colgate-Palmolive Company...
May 07, 2018 04:15 pm ET
Danaher to Present at Bank of America Merrill Lynch Health Care Conference
WASHINGTON, May 7, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Tuesday, May 15, 2018 at 8:00 a.m. PT. The audio will be simultaneously webcast on www.danaher.com. ...
May 01, 2018 11:35 am ET
Beckman Coulter Launches the DxH 900 Hematology Analyzer
BREA, Calif., May 1, 2018 /PRNewswire/ -- Beckman Coulter announced today the release of the DxH 900 hematology analyzer, giving mid- to high-volume clinical laboratories the ability to perform complete blood count and white blood cell differential tests with minimal repeats. The DxH 900 is now available for sale in Europe, the United States, Canada, Australia and New Zealand. The DxH 900 analyzer offers advanced technologies to support patient care, by delivering the right results the first time. Foundational to the system are its core technologies, including the enhanced Coulter Principle,...
Apr 19, 2018 06:00 am ET
Danaher Reports First Quarter 2018 Results
WASHINGTON, April 19, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2018. For the quarter ended March 30, 2018, net earnings were $566.6 million, or $0.80 per diluted share which represents a 16.0% year-over-year increase....
Apr 10, 2018 11:33 am ET
Beckman Coulter Diagnostics Announces Worldwide Commercialization of the Access Sensitive Estradiol
BREA, Calif., April 10, 2018 /PRNewswire/ -- Beckman Coulter Diagnostics today announced commercialization of its Access Sensitive Estradiol in the U.S., with simultaneous commercial availability of its assay in the majority of global markets. The test is commonly ordered for detecting estradiol levels in women, children and men. With low-end precision and state-of-the-art sensitivity, the Access Sensitive Estradiol assay will help laboratories deliver more accurate results for patients seeking answers to reproductive health questions. ...
Mar 19, 2018 05:08 pm ET
Danaher Schedules First Quarter 2018 Earnings Conference Call
WASHINGTON, D.C., March 19, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2018 on Thursday, April 19, 2018 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Mar 09, 2018 05:59 am ET
Danaher to Acquire Integrated DNA Technologies
WASHINGTON, March 9, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") and Integrated DNA Technologies ("IDT") announced today that Danaher has entered into a definitive agreement to acquire IDT, a privately-held provider of high-value consumables for genomics applications in molecular biology, qPCR, next generation sequencing, synthetic biology, gene editing and molecular diagnostics.  ...
Mar 07, 2018 05:00 am ET
Danaher Provides Update On First Quarter 2018 Financial Performance
WASHINGTON, March 7, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced today that it expects first quarter 2018 adjusted diluted net earnings per share to be above the high-end of the Company's previously communicated guidance range....
Mar 06, 2018 08:00 am ET
New Research: Key Drivers of Growth for Callon Petroleum, Dynegy, Danaher, HollyFrontier, Aevi Genomic Medicine, and Apache — Factors of Influence, Major Initiatives and Sustained Production
NEW YORK, March 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Callon Petroleum Company (NYSE:CPE), Dynegy Inc....
Feb 20, 2018 03:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Feb. 20, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on April 27, 2018 to holders of record on March 29, 2018. ...
Feb 14, 2018 03:15 pm ET
Danaher To Present At Barclays Industrial Select Conference
WASHINGTON, Feb. 14, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Wednesday, February 21, 2018 at 10:20 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ...
Jan 30, 2018 05:00 am ET
Danaher Announces Transition Plan For Chief Financial Officer
WASHINGTON, Jan. 30, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that, effective January 1, 2019, Matthew R. McGrew, Group CFO of the Company's Diagnostics and Dental platforms, will succeed Daniel L. Comas as Chief Financial Officer. Mr. Comas will continue as an Executive Vice President of the Company, and a member of the Office of the Chief Executive, effective January 1, 2019 as he begins a gradual transition to retirement. ...
Jan 30, 2018 05:00 am ET
Danaher Reports Fourth Quarter And Full Year 2017 Results
WASHINGTON, Jan. 30, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2017. For the quarter ended December 31, 2017, net earnings were $856.6 million, or $1.21 per diluted share which represents a 13.0% year-over-year increase....
Jan 08, 2018 07:05 pm ET
Danaher CEO To Comment On Financial Performance
WASHINGTON, Jan. 8, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2017 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 9:00 a.m. PT. Mr. Joyce will communicate that Danaher's fourth quarter 2017 adjusted diluted net earnings per share and core revenue growth are both expected to be above the high-end of the Company's previously announced guidance ranges....
Jan 02, 2018 03:15 pm ET
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 2, 2018 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 9, 2018 at 9:00 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Dec 27, 2017 03:15 pm ET
Danaher Schedules Fourth Quarter 2017 Earnings Conference Call
WASHINGTON, Dec. 27, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2017 on Tuesday, January 30, 2018 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Dec 14, 2017 05:00 am ET
Danaher Initiates 2018 Outlook
WASHINGTON, Dec. 14, 2017 /PRNewswire/ -- Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (NYSE: DHR) (the "Company") initiated its 2018 outlook. The Company anticipates that 2018 diluted net earnings per share will be in the range of $3.50 to $3.60....
Nov 28, 2017 07:00 am ET
Danaher Announces Leadership Appointment
WASHINGTON, Nov. 28, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company's Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company.  ...
Nov 27, 2017 01:40 pm ET
Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly
BREA, Calif., Nov. 27, 2017 /PRNewswire/ -- Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals, Beckman Coulter plans in the future to sell directly to its customers a natriuretic peptide assay for its Access Family of Immunoassay Systems. Currently, Beckman Coulter customers have access to a BNP assay which, although developed and manufactured by Beckman Coulter, is sold exclusively by Quidel and its designated distributors. Quidel took over this c...
Nov 27, 2017 01:40 pm ET
Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Directly
BREA, Calif., Nov. 27, 2017 /CNW/ -- Beckman Coulter is committed to ensuring customers receive the highest quality assays, on-time, to help healthcare and laboratory professionals provide better patient care. To further these goals, Beckman Coulter plans in the future to sell directly to its customers a natriuretic peptide assay for its Access Family of Immunoassay Systems. Currently, Beckman Coulter customers have access to a BNP assay which, although developed and manufactured by Beckman Coulter, is sold exclusively by Quidel and its designated distributors. Quidel took over this commerci...
Nov 14, 2017 05:30 pm ET
Danaher to Webcast Investor and Analyst Meeting
WASHINGTON, Nov. 14, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Investor and Analyst Meeting on December 14, 2017 beginning at 9:30 a.m. ET and concluding at approximately 1:00 p.m. The link to the webcast will be available on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the video webcast will be available following the presentation.  ...
Nov 07, 2017 07:40 am ET
Recent Analysis Shows Philip Morris, Danaher, Skechers, Sally Beauty, Spectrum Pharma, and Textron Market Influences – Renewed Outlook, Key Drivers of Growth
NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Philip Morris International Inc. (NYSE:PM), Danaher...
Nov 01, 2017 05:15 pm ET
Danaher to Present at Baird Industrial Conference
WASHINGTON, Nov. 1, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird 2017 Global Industrial Conference in Chicago, Illinois on Wednesday, November 8, 2017 at 10:00 a.m. CT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Oct 19, 2017 07:00 am ET
Danaher Reports Third Quarter 2017 Results
WASHINGTON, Oct. 19, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2017.  For the quarter ended September 29, 2017, net earnings were $572.1 million, or $0.81 per diluted share which represents a 42.0% year-over-year increase....
Sep 20, 2017 05:15 pm ET
Danaher Schedules Third Quarter 2017 Earnings Conference Call
WASHINGTON, Sept. 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2017 on Thursday, October 19, 2017 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Sep 12, 2017 05:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 12, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on October 27, 2017 to holders of record on September 29, 2017. ...
Aug 31, 2017 05:15 pm ET
Danaher To Present At Vertical Research Partners Industrial Conference
WASHINGTON, Aug. 31, 2017 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in Westbrook, Connecticut on Thursday, September 7, 2017 at 8:45 a.m. ET....
Jul 20, 2017 07:00 am ET
Danaher Reports Second Quarter 2017 Results
WASHINGTON, July 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2017.  For the quarter ended June 30, 2017, net earnings were $557.3 million, or $0.79 per diluted share which represents a 31.5% year-over-year increase....
Jun 21, 2017 05:15 pm ET
Danaher Schedules Second Quarter 2017 Earnings Conference Call
WASHINGTON, June 21, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2017 on Thursday, July 20, 2017 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Jun 20, 2017 09:11 am ET
Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering
WASHINGTON, June 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance S.A. ("Danaher International"), has priced an offering of:...
Jun 08, 2017 05:15 pm ET
Danaher to Present at Goldman Sachs Global Healthcare Conference
WASHINGTON, June 8, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, and Executive Vice President Rainer Blair will be presenting at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 14, 2017 at 10:00 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 25, 2017 05:15 pm ET
Danaher To Present At Bernstein Strategic Decisions Conference
WASHINGTON, May 25, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, June 1, 2017 at 8:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 15, 2017 05:15 pm ET
Danaher To Present At Electrical Products Group Conference
WASHINGTON, May 15, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 22, 2017 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 10, 2017 05:45 pm ET
Danaher To Present At Bank Of America Merrill Lynch Health Care Conference
WASHINGTON, May 10, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada on Wednesday, May 17, 2017 at 9:20 a.m. PT. The audio will be simultaneously webcast on www.danaher.com.  ...
May 09, 2017 05:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, May 9, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on July 28, 2017 to holders of record on June 30, 2017. ...
Apr 20, 2017 07:00 am ET
Danaher Reports First Quarter 2017 Results
WASHINGTON, April 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter of 2017. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended March 31, 2017, net earnings were $483.8 million, or $0.69 per diluted share which represents an 18.0% year-over-year decrease....
Mar 20, 2017 05:15 pm ET
Danaher Schedules First Quarter 2017 Earnings Conference Call
WASHINGTON, March 20, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2017 on Thursday, April 20, 2017 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Feb 21, 2017 04:15 pm ET
Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board
WASHINGTON, Feb. 21, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has appointed Raymond C. Stevens, Ph.D. to its Board of Directors....
Feb 21, 2017 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Feb. 21, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on April 28, 2017 to holders of record on March 31, 2017. ...
Feb 16, 2017 04:15 pm ET
Danaher To Present At Barclays Industrial Select Conference
WASHINGTON, Feb. 16, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 23, 2017 at 9:10 a.m. ET. The audio will be simultaneously webcast on www.danaher.com.  ...
Jan 31, 2017 06:00 am ET
Danaher Reports Fourth Quarter And Full Year 2016 Results
WASHINGTON, Jan. 31, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2016. All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended December 31, 2016, net earnings were $747.0 million, or $1.07 per diluted share which represents a 42.5% year-over-year increase....
Jan 11, 2017 04:15 pm ET
Danaher Schedules Fourth Quarter 2016 Earnings Conference Call
WASHINGTON, Jan. 11, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2016 on Tuesday, January 31, 2017 beginning at 7:30 a.m. ET and lasting approximately 1 hour....
Jan 04, 2017 04:15 pm ET
Danaher To Present At J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 4, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 10, 2017 at 11:30 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Dec 15, 2016 06:00 am ET
Danaher Initiates 2017 Outlook
WASHINGTON, Dec. 15, 2016 /PRNewswire/ -- Ahead of its annual investor and analyst meeting to be held in New York City, Danaher Corporation (NYSE:DHR) (the "Company") initiated its 2017 outlook. The Company anticipates that 2017 diluted net earnings per share will be in the range of $3.13 to $3.23....
Dec 06, 2016 04:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Dec. 6, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.125 per share payable on January 27, 2017 to holders of record on December 30, 2016. ...
Dec 01, 2016 08:00 am ET
Danaher announces leadership appointment
WASHINGTON, Dec. 1, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2017, Rainer Blair has been promoted to Executive Vice President of Danaher Corporation, with responsibility for the Company's $5 billion Life Sciences platform. ...
Nov 14, 2016 04:15 pm ET
Danaher To Webcast Investor And Analyst Meeting
WASHINGTON, Nov. 14, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on December 15, 2016 beginning at 9:30 a.m. ET and concluding at approximately 1:00 p.m. The link to the webcast will be available on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the video webcast will be available following the presentation.  ...
Nov 04, 2016 08:20 pm ET
Danaher Completes Acquisition Of Cepheid
WASHINGTON, Nov. 4, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced that today it completed its acquisition of Cepheid (NASDAQ: CPHD)....
Oct 31, 2016 05:15 pm ET
Danaher to Present at Baird Industrial Conference
WASHINGTON, Oct. 31, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Baird 2016 Global Industrial Conference in Chicago, Illinois on Wednesday, November 9, 2016 at 8:00 a.m. CT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Oct 20, 2016 07:00 am ET
Danaher Reports Third Quarter 2016 Results
WASHINGTON, Oct. 20, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2016. All results in this release reflect only continuing operations unless otherwise noted.  For the quarter ended September 30, 2016, net earnings were $402.6 million, or $0.57 per diluted share, which represents a 6% year-over-year increase....
Sep 20, 2016 05:15 pm ET
Danaher Schedules Third Quarter 2016 Earnings Conference Call
WASHINGTON, Sept. 20, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2016 on Thursday, October 20, 2016 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Sep 13, 2016 05:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Sept. 13, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.125 per share payable on October 28, 2016 to holders of record on September 30, 2016. ...
Sep 08, 2016 05:30 pm ET
Danaher To Present At Morgan Stanley Laguna Conference
WASHINGTON, Sept. 8, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley Laguna Conference in Dana Point, California on Thursday, September 15, 2016 at 9:20 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Sep 06, 2016 04:17 pm ET
Cepheid Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy Of Price And Process In Proposed Sale Of Cepheid
NEW ORLEANS, Sept. 6, 2016 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cepheid ("Cepheid" or the "Company") (NASDAQ: CPHD) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Cepheid will receive only $53.00 in cash for each share of Cepheid that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company....
Sep 06, 2016 08:46 am ET
CEPHEID (CPHD) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Cepheid; Are Shareholders Getting a Fair Price?
SAN DIEGO, Sept. 6, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Cepheid (NASDAQ: CPHD) breached their fiduciary duties in connection with the proposed sale of the Company to Danaher Corporation (NYSE: DHR)....
Sep 06, 2016 07:30 am ET
Cepheid Agrees To Be Acquired By Danaher Corporation For $53 Per Share In Cash
SUNNYVALE, Calif., Sept. 6, 2016 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced that it has entered into a definitive agreement with Danaher Corporation (NYSE: DHR) under which Danaher will acquire all of the outstanding shares of Cepheid common stock for $53 per share in cash, or a total enterprise value of approximately $4 billion including indebtedness and net of acquired cash....
Sep 06, 2016 07:30 am ET
Danaher To Acquire Cepheid For $53.00 Per Share, Or Approximately $4 Billion
WASHINGTON, Sept. 6, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53.00 per share in cash, or a total enterprise value of approximately $4 billion including indebtedness and net of acquired cash.  ...
Aug 23, 2016 07:00 am ET
Danaher to Present At Vertical Research Partners Industrial Conference
WASHINGTON, Aug. 23, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Vertical Research Partners Industrial Conference in Westbrook, Connecticut on Wednesday, September 7, 2016 at 10:15 a.m. ET....
Jul 25, 2016 07:01 am ET
Danaher Reports Second Quarter 2016 Results
WASHINGTON, July 25, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2016. For the quarter ended July 1, 2016, net earnings from continuing operations were $656.7 million, or $0.94 per diluted share on a GAAP basis, which represents a 5% year-over-year decrease.  The results for the second quarter include the operations of Fortive Corporation ("Fortive"), which was spun-off to Danaher's shareholders on July 2, 2016....
Jul 15, 2016 10:29 am ET
Danaher Corporation To Redeem Senior Notes
WASHINGTON, July 15, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will redeem all of its $500,000,000 aggregate principal amount of 5.625% Senior Notes due 2018 (the "2018 Notes"), $750,000,000 aggregate principal amount of 5.40% Senior Notes due 2019 (the "2019 Notes") and $600,000,000 aggregate principal amount of 3.900% Senior Notes due 2021 (the "2021 Notes" and together with the 2018 Notes and 2019 Notes, the "Notes"), in each case at a redemption price equal to the outstanding principal amount of such redeemed series of Notes and a make-whole premium as ...
Jul 14, 2016 05:15 pm ET
Danaher Announces Appointment of Robert J. Hugin to Danaher Board
WASHINGTON, July 14, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has appointed Robert J. Hugin to Danaher's Board of Directors. The Board also appointed Mr. Hugin to the Compensation Committee of Danaher's Board....
Jul 02, 2016 01:01 am ET
Danaher Corporation Completes Separation of Fortive Corporation
WASHINGTON, July 2, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it has completed the separation of its Test & Measurement segment, Industrial Technologies segment (other than its Product Identification platform) and Retail/Commercial Petroleum platform through the spin-off of Fortive Corporation. Fortive will begin "regular way" trading on the New York Stock Exchange on July 5, 2016, under the symbol "FTV." ...
Jun 23, 2016 07:00 pm ET
Danaher Schedules Second Quarter 2016 Earnings Conference Call
WASHINGTON, June 23, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2016 on Monday, July 25, 2016 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Jun 23, 2016 06:46 pm ET
Albemarle and Fortive Set to Join the S&P 500; EMCOR to Join S&P MidCap 400; Inteliquent to Join S&P SmallCap 600
NEW YORK, June 23, 2016 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:...
Jun 21, 2016 07:00 am ET
Fortive Announces Equity Investor Meetings For Upcoming Spin-off From Danaher And Provides Financial Outlook As Standalone Company
WASHINGTON, June 21, 2016 /PRNewswire/ -- Fortive Corporation ("Fortive") (NYSE: FTV.WI) announced today that it will begin making presentations to the equity investment community in preparation for its planned July 2, 2016 spin-off from Danaher Corporation (NYSE: DHR) ("Danaher"), including a webcast presentation today at approximately 12:30 p.m. ET. The meetings will be led by President and Chief Executive Officer, James A. Lico, and Senior Vice President and Chief Financial Officer, Charles E. McLaughlin.  ...
Jun 09, 2016 05:15 pm ET
Fortive Prices Private Offering of Additional 4.300% Senior Notes due 2046
WASHINGTON, June 9, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive has priced the previously announced offering of an additional $200 million aggregate principal amount of 4.300% senior notes due 2046 (the "additional 2046 notes"). On June 6, 2016, Fortive agreed to issue $350 million aggregate principal amount of 4.300% senior notes due 2046 (the "prior 2046 notes" and together with the additional 2046 notes, the "2046 notes") pursuant to a private offering.  The addi...
Jun 09, 2016 11:25 am ET
Fortive Announces Private Offering of Additional 4.300% Senior Notes due 2046
WASHINGTON, June 9, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive intends to offer up to an additional $200 million aggregate principal amount of 4.300% senior notes due 2046 (the "additional 2046 notes"), subject to market conditions and other factors. On June 6, 2016, Fortive agreed to issue $350 million aggregate principal amount of 4.300% senior notes due 2046 (the "prior 2046 notes" and together with the additional 2046 Notes, the "2046 notes") pursuant to a...
Jun 06, 2016 07:32 pm ET
Fortive Prices Private Offering of Senior Notes
WASHINGTON, June 6, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive has priced the previously announced offering of $300 million of 1.800% senior notes due 2019, $750 million of 2.350% senior notes due 2021, $900 million of 3.150% senior notes due 2026 and $350 million of 4.300% senior notes due 2046. The closing of the offering is expected to occur on June 20, 2016, subject to customary closing conditions. Danaher will guarantee the notes until the spin-off occurs. The...
Jun 06, 2016 10:06 am ET
Fortive Announces Private Offering of Senior Notes
WASHINGTON, June 6, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) and Fortive Corporation announced today, in connection with the planned spin-off of Fortive from Danaher, that Fortive intends to offer senior notes, subject to market conditions and other factors. Danaher will guarantee the notes until the spin-off occurs. Fortive intends to use the net proceeds from the sale of the notes to make payments to Danaher as consideration for the contribution of assets to Fortive by Danaher in connection with the separation, and to pay related fees and expenses and for general corporate purp...
Jun 02, 2016 05:15 pm ET
Danaher To Present At Goldman Sachs Global Healthcare Conference
WASHINGTON, June 2, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Goldman Sachs Global Healthcare Conference in Rancho Palos Verdes, California on Thursday, June 9 at 8:00 a.m. PT. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
Jun 01, 2016 05:15 pm ET
Danaher Declares Pro Rata Dividend Of Fortive Common Stock And Announces Expected "When-Issued" Trading Of Fortive Common Stock
WASHINGTON, June 1, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced that the Danaher Board of Directors has declared a pro rata dividend of all of the common stock of Fortive Corporation to Danaher stockholders of record as of the close of business on June 15, 2016 (the "Record Date"). The dividend is payable on July 2, 2016 ("Distribution Date") in connection with the previously announced separation of Danaher's existing Test & Measurement segment, Industrial Technologies segment (excluding the Product Identification platform) and Retail/Commercial Petroleum platfor...
May 25, 2016 07:00 pm ET
Danaher To Present At Bernstein Strategic Decisions Conference
WASHINGTON, May 25, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Bernstein Strategic Decisions Conference in New York City on Thursday, June 2 at 9:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 20, 2016 06:55 pm ET
Fortive Form 10 Registration Statement Declared Effective
WASHINGTON, May 20, 2016 /PRNewswire/ -- Today, Danaher Corporation (NYSE: DHR) ("Danaher") announced that the U.S. Securities and Exchange Commission has declared effective the Registration Statement on Form 10 of Fortive Corporation ("Fortive"). The Registration Statement on Form 10 includes information regarding Fortive's business and the spin-off of Fortive from Danaher, which is expected to be completed on July 2, 2016. In addition, on May 12, 2016, the New York Stock Exchange authorized Fortive for listing on the exchange with the ticker symbol "FTV."...
May 19, 2016 06:00 pm ET
Danaher And Fortive To Webcast Investor And Analyst Event
WASHINGTON, May 19, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) ("Danaher") and Fortive Corporation ("Fortive") invite you to listen to a live webcast presentation of our investor and analyst event on Thursday, May 26, 2016. The webcast will begin at approximately 12:00 p.m. ET and conclude at approximately 2:30 p.m. ET. The event, to be hosted at our Gilbarco Veeder-Root facility in Greensboro, North Carolina, will include an overview of Fortive and a comprehensive look at our Gilbarco Veeder-Root businesses. A link to the webcast and accompanying slide presentation will be availabl...
May 12, 2016 06:00 pm ET
Danaher To Present At Electrical Products Group Conference
WASHINGTON, May 12, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Electrical Products Group Conference in Longboat Key, Florida on Monday, May 16 at 10:00 a.m. ET. The audio will be simultaneously webcast and the presentation will be archived on www.danaher.com.  ...
May 10, 2016 05:15 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, May 10, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on July 29, 2016 to holders of record on June 3, 2016. ...
May 04, 2016 07:46 am ET
Danaher Announces Anticipated Fortive Separation Date
WASHINGTON, May 4, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced that it expects to complete the spin-off of Fortive Corporation on July 2, 2016. ...
Apr 21, 2016 07:00 am ET
Danaher Reports Record First Quarter 2016 Results
WASHINGTON, April 21, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the first quarter 2016. All financial metrics in this press release reflect Danaher's continuing operations....
Mar 28, 2016 07:00 pm ET
Danaher Schedules First Quarter 2016 Earnings Conference Call
WASHINGTON, March 28, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2016 on Thursday, April 21, 2016 beginning at 8:00 a.m. ET and lasting approximately 1 hour....
Mar 11, 2016 06:23 pm ET
Danaher, Duke Energy and NextEra Energy Set to Join the S&P 100
NEW YORK, March 11, 2016 /PRNewswire/ -- S&P 500 constituents Danaher Corp. (NYSE:DHR), Duke Energy Corp. (NYSE:DUK) and NextEra Energy Inc. (NYSE:NEE) will replace S&P 500 constituents Devon Energy Corp. (NYSE:DVN), Anadarko Petroleum Corp. (NYSE:APC) and Norfolk Southern Corp. (NYSE:NSC) in the S&P 100 after the close of trading on Friday, March 18. All companies being removed from the S&P 100 will remain in the S&P 500. All companies being added to the S&P 100 are more representative of the U.S. mega-cap equity space....
Mar 02, 2016 04:01 pm ET
Danaher to Present at J.P. Morgan Aviation, Transportation and Industrials Conference
WASHINGTON, March 2, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the J.P. Morgan Aviation, Transportation and Industrials Conference in New York, New York on Wednesday, March 9, 2016 at 3:30 p.m. EST. The audio will be simultaneously webcast on www.danaher.com. ...
Feb 29, 2016 05:00 pm ET
Danaher Announces Change To Quarterly Dividend Record Date
WASHINGTON, Feb. 29, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a change of the previously announced record date for the Company's upcoming regular quarterly dividend to March 24, 2016 from March 25, 2016. The dividend amount of $0.16 per share will now be payable April 29, 2016 to holders of record as of March 24, 2016....
Feb 23, 2016 04:30 pm ET
Danaher Announces Quarterly Dividend
WASHINGTON, Feb. 23, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.16 per share payable on April 29, 2016 to holders of record on March 25, 2016. ...
Feb 16, 2016 04:01 pm ET
Danaher To Present At Barclays Industrial Select Conference
WASHINGTON, Feb. 16, 2016 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the Barclays Industrial Select Conference in Miami, Florida on Thursday, February 18, 2016 at 9:05 a.m. EST. The audio will be simultaneously webcast on www.danaher.com. ...
Jan 26, 2016 06:00 am ET
Danaher Reports Record Fourth Quarter And Full Year 2015 Results
WASHINGTON, Jan. 26, 2016 /PRNewswire/ -- Danaher Corporation (NYSE:DHR) today announced results for the fourth quarter and full year 2015. All financial metrics in this press release reflect Danaher's continuing operations....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.